Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > High-resolution optical coherence tomography improves precision in AMD diagnosis
  • Diagnostics

High-resolution optical coherence tomography improves precision in AMD diagnosis

Kelsey Moroz

High-resolution optical coherence tomography (HR-OCT) significantly improves the accuracy and reliability of identifying and classifying atrophic lesions associated with age-related macular degeneration (AMD) when compared to standard resolution OCT, according to a study.

The findings highlight the superiority of HR-OCT in both qualitative and quantitative assessments, particularly in identifying specific atrophic features and measuring associated parameters.

In this prospective, observational, cross-sectional study, 60 patients (60 eyes) diagnosed with AMD, underwent volume OCT scanning using both HR-OCT and standard resolution OCT devices. Trained graders reviewed and graded the scans, pinpointing specific regions of interest for subsequent analysis. The primary focus of the study was on identifying and classifying complete retinal pigment epithelium and outer retinal atrophy (cRORA), incomplete RORA (iRORA), and other non-atrophic AMD features.

The results showcased substantial to perfect agreement among readers for classifying atrophic lesions, with a noteworthy agreement of 0.88 for HR-OCT and 0.82 for standard resolution OCT. Notably, HR-OCT demonstrated higher accuracy in identifying iRORA lesions compared to its standard counterpart.

In the realm of qualitative assessment, HR-OCT outshone standard OCT, particularly in identifying external limiting membrane (ELM) and ellipsoid zone (EZ) disruption, with agreements of 0.95 and 0.94, respectively. Quantitative measurements of features such as hypertransmission defects, retinal pigment epithelium attenuation/disruption, EZ disruption width, and ELM disruption width exhibited excellent inter-reader agreement with HR-OCT (> 0.90 for all features). In contrast, standard OCT showed only moderate agreement (0.51-0.60) for these quantitative features.

Reference
Mahmoudi A, Corradetti G, Emamverdi M, et al. Atrophic Lesions Associated with Age-related Macular Degeneration: High-resolution versus Standard Optical Coherence Tomography. Ophthalmol Retina. 2023;S2468-6530(23)00513-4. doi: 10.1016/j.oret.2023.10.011. Epub ahead of print. PMID: 37871680.

 

 

Share

Related Content

  • Diagnostics

Diabetes linked to higher risk of ulcerative keratitis in US study

  • Glaucoma

Review highlights potential role of electrophysiology in early glaucoma detection

  • Diagnostics

AI-based diagnostics show promise for early ocular disease detection

  • Diagnostics

Tear biomarkers may help predict response to low-level light therapy after cataract surgery

  • Diagnostics

Traditional photoscreener outperformed retinal birefringence scanner in pediatric vision screening study

  • Diagnostics

Optometrists outperform AI in diagnosing and managing age-related macular degeneration

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon